Company:  FOREST LABORATORIES INC (FRX)
Form Type:  10-K
Filing Date:  5/23/2013 
CIK:  0000038074 
Address:  909 THIRD AVENUE 
City, State, Zip:  NEW YORK, New York 10022 
Telephone:  (212) 421-7850 
Fiscal Year:  09/13 
Last Trade
Last Trade: 
$91.45  
Change: 
-0.20 (-0.22%)  
Trade Time: 
Apr 24  
Market Cap: 
$24.78B
Description of Business
Forest Laboratories, Inc. and its subsidiaries (herein and referred to as �Forest,� �the Company,� �we,� or �us�) develop, manufacture and sell branded forms of ethical drug products most of which require a physician's prescription. Our most important products in the United States (U.S.) are marketed directly, or �detailed,� to physicians by our salesforces. We emphasize detailing to physicians those branded ethical drugs which we believe have the most benefit to patients and potential for growth. We also focus on the development and introduction of new products, including products developed in collaboration with licensing partners. Our products include those developed by us, those developed in conjunction with our partners and those acquired from other pharmaceutical companies and integrated into our marketing and distribution systems.
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
      Item 1A. Risk Factors
        The Effective Rate of Taxation upon Our Results of ...
      Item 1B. Unresolved Staff Comments
      Item 3. Legal Proceedings
      Item 4. Mine Safety Disclosures
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    VALUATION AND QUALIFYING ACCOUNTS
    PART II
      Item 9. Changes in and Disagreements With Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accountant Fees and Services
    PART IV
      Item 15. Exhibits, Financial Statement Schedules
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED ...
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED ...
  EXHIBIT 10.14
  EXHIBIT 21
    SUBSIDIARIES
  EXHIBIT 23
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
BROKERAGE PARTNERS